|
58
|
253
|
1h8iH |
X-ray crystal structure of human alpha-thrombin with a tripeptide phosphonate inhibitor. |
|
61
|
251
|
1h8dH |
X-ray structure of the human alpha-thrombin complex with a tripeptide phosphonate inhibitor. |
|
3
|
36
|
1ghvL |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
78
|
305
|
1jwtA |
Crystal structure of thrombin in complex with a novel bicyclic lactam inhibitor |
|
50
|
257
|
1gj5H |
Selectivity at s1, h2o displacement, upa, tpa, ser190/ala190 protease, structure-based drug design |
|
53
|
257
|
1ghvH |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
1
|
36
|
1ghxL |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
2
|
36
|
1gj5L |
Selectivity at s1, h2o displacement, upa, tpa, ser190/ala190 protease, structure-based drug design |
|
53
|
257
|
1ghyH |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
1
|
36
|
1ghyL |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
1
|
36
|
1ghwL |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
3
|
28
|
1gj4L |
Selectivity at s1, h2o displacement, upa, tpa, ser190/ala190 protease, structure-based drug design |
|
52
|
257
|
1ghwH |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
52
|
257
|
1ghxH |
A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site |
|
52
|
258
|
1gj4H |
Selectivity at s1, h2o displacement, upa, tpa, ser190/ala190 protease, structure-based drug design |
|
3
|
36
|
1fphL |
The interaction of thrombin with fibrinogen: a structural basis for its specificity |
|
3
|
27
|
1g32A |
Thrombin inhibitor complex |
|
3
|
26
|
1fpcL |
Active site mimetic inhibition of thrombin |
|
3
|
27
|
1g30A |
Thrombin inhibitor complex |
|
53
|
256
|
1fpcH |
Active site mimetic inhibition of thrombin |
|
56
|
259
|
1jmoH |
Crystal structure of the heparin cofactor ii-s195a thrombin complex |
|
59
|
287
|
1g37A |
Crystal structure of human alpha-thrombin complexed with bch-10556 and exosite-directed peptide |
|
55
|
259
|
1fphH |
The interaction of thrombin with fibrinogen: a structural basis for its specificity |
|
63
|
259
|
1g32B |
Thrombin inhibitor complex |
|
62
|
259
|
1g30B |
Thrombin inhibitor complex |
|
4
|
45
|
1jouA |
Crystal structure of native s195a thrombin with an unoccupied active site |
|
4
|
36
|
1ettL |
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics |
|
2
|
36
|
1etrL |
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics |
|
70
|
289
|
1eojA |
Design of p1' and p3' residues of trivalent thrombin inhibitors and their crystal structures |
|
53
|
259
|
1etsH |
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics |
|
50
|
259
|
1ettH |
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics |
|
51
|
259
|
1etrH |
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics |
|
67
|
289
|
1eolA |
Design of p1' and p3' residues of trivalent thrombin inhibitors and their crystal structures |
|
1
|
36
|
1etsL |
Refined 2.3 angstroms x-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors napap, 4-tapap and mqpa: a starting point for improving antithrombotics |
|
3
|
27
|
1eb1L |
Complex structure of human thrombin with n-methyl-arginine inhibitor |
|
60
|
257
|
1eb1H |
Complex structure of human thrombin with n-methyl-arginine inhibitor |
|
3
|
29
|
1dwcL |
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors |
|
1
|
36
|
1e0fA |
Crystal structure of the human alpha-thrombin-haemadin complex: an exosite ii-binding inhibitor |
|
61
|
259
|
1dx5M |
Crystal structure of the thrombin-thrombomodulin complex |
|
3
|
28
|
1dweL |
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors |
|
3
|
29
|
1dwbL |
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors |
|
3
|
36
|
1dx5A |
Crystal structure of the thrombin-thrombomodulin complex |
|
56
|
257
|
1dwbH |
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors |
|
54
|
257
|
1dwdH |
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors |
|
72
|
295
|
1dojA |
Crystal structure of human alpha-thrombin*rwj-51438 complex at 1.7 a |
|
54
|
257
|
1dweH |
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors |
|
3
|
29
|
1dwdL |
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors |
|
54
|
257
|
1dwcH |
Crystallographic analysis at 3.0-angstroms resolution of the binding to human thrombin of four active site-directed inhibitors |
|
52
|
257
|
1e0fD |
Crystal structure of the human alpha-thrombin-haemadin complex: an exosite ii-binding inhibitor |
|
2
|
33
|
1dm4A |
Ser195ala mutant of human thrombin complexed with fibrinopeptide a (7-16) |
